abstract |
The present invention relates to a novel mutant protein derived from lipocalin of human tears. The present invention also provides a nucleic acid encoding the mutant protein and a method of generating the same. In addition, the present invention provides a method for producing said mutant protein. Finally, the present invention can provide a pharmaceutical composition comprising the lipocalin mutant protein as well as various uses of the mutant protein.n n n n Lipocalin mutant protein, IL-4 receptor alpha, VEGF receptor |